Introduction
The ryanodine receptor RyR is a family of Ca The type 1 RyR isoform RyR1 is known as the skeletal-type RyR based on the initial puri cation and cDNA cloning from skeletal muscle 2 . RyR1 is also expressed in the brain, storage sites such as endoplasmic reticulum ER . The mRNA transcript encoding fulllength RyR1 is approximately 16 kb and is mainly distributed in excitable cells. A 2.4-kb mRNA splice variant from the 3 -terminal region of the RyR1 gene coexists speci cally in brain together with the full-length form, although the functions of this brain-specific splice variant remain unclear. To investigate the short form of RyR1 in intracellular Ca 2 signaling in brain at the cellular level, we established an experimental system whereby the green fluorescent protein GFP -tagged brain-speci c variant of RyR1 is coexpressed with the full-length protein in the same cell. Both forms of RyR1 were localized in the ER. Caffeine-induced Ca 2 -release activities in cells expressing both the brain-speci c and full-length RyR1 were reduced compared to cells expressing only the full-length form of RyR1. These results suggested that coexpression of the brain-specific splice variant of RyR1 with its full-length counterpart modulates intracellular Ca 2 signaling by acting as a dominant-negative subunit of the Ca although in much smaller amounts than found in striated muscle 3, 4 
Materials and Methods
The transfection ef ciency in cells depends on the size of the target DNA, and the fulllength RyR1 cDNA about 16,000 bp was too long to be coexpressed quantitatively with the shorter cDNA of the brain-speci c RyR1 transcript 2,400 bp transfected into the same cells. We therefore established the following methods to coexpress the two RyR1 cDNAs.
Establishment of stable cell line induced to express full-length RyR1
The RyR1 was carried out as previously described 9 to confirm the expression of exogenous RyR1 in the cells.
Coexpression of the brain-speci c splice variant of RyR1 in the full-length RyR1-expressing cells
The domain corresponding to the brain-speci c transcript of RyR1 5 , which is approxi- averaged over the whole area sampled. Images were captured by a high-sensitivity chargecoupled device digital camera DP70, Olympus using image-capture software DP Control, Olympus , and analyzed using ImageJ. Changes in the ratios of the uorescence intensity at 345 nm to that at 380 nm were normalized to the average resting value before the rst drug application.
Reagents
Caffeine was purchased from Wako Pure Chemicals Industries.
Data analysis
All results from the normalized values of the uorescence ratios are expressed as mean SEM. Statistical differences between groups were evaluated by unpaired t-tests. A P value of 0.0005 or less was considered to indicate a signi cant difference between groups.
Results
Prior to applying the Flp-In T-REx system, we performed a trial with a simple method to express two different genes transiently using a single expression vector such as the pIRES internal ribosome entry site bicistronic expression vector Clontech Laboratories, Mountain
View, CA or pBI bidirectional expression vector Clontech 13 . However, the nal size of these expression vectors 250,000 bp was too large for the ef cient expression of both recombinant proteins. Therefore, we instead established stable cell lines expressing full-length RyR1 encoded by the larger vectors, and then transiently expressed the brain-speci c form of RyR1 in the stably expressing cells by standard transfection procedures.
Establishment of stable HEK293 cell lines induced to express full-length RyR1
Using showing much stronger uorescent signal in the cytoplasm than in the nucleus, as previously reported [12] [13] [14] . These results indicated highly reproducible expression of exogenous RyR1 at the expected location from cell to cell and from clone to clone using this experimental system.
Expression of the brain-speci c transcript of RyR1 in HEK293 cells
We constructed the truncated form of RyR1cDNA corresponding to the brain-specific transcript of RyR1 to be expressed as a GFP-fusion protein. Stable cell lines inducibly expressing the brain-specific form of RyR1 were also established by the Flp-In T-Rex system. GFP-fluorescence was observed for both clones inducibly expressing the short forms tagged by GFP at its N-or C-terminus respectively, although the signal intensity was slightly stronger with the GFP at the C-terminal of RyR1 compared to tagging at the N-terminus Fig. 2A and 2C . The intracellular distribution of the GFP-fusion proteins was predominantly cytoplasmic Fig. 2A and 2C , as described previously with full-length RyR1-GFP fusions 12, 14 . These results suggested that both of the GFP-tagged brain-speci c RyR1s
were expressed appropriately at intracellular Ca 
Coexpression of the brain-speci c transcript of RyR1 with full-length RyR1 in HEK293 cells
We introduced the expression vectors encoding the brain-specific short form of 
Discussion
In this study, we developed an experimental system for coexpressing two genes that differ by approximately 10-fold in length in the same cells. We showed the novel nding that has also been reported in muscle biopsies from MH patients 8, 13 . The brain-speci c short form of RyR1 might therefore confer local protective effects on the MH symptoms by blocking the function of the MH-related regions of full-length RyR1. RyR genes contain more than 100 exons, and many tissue-specific or developmentally regulated splice variants have been reported [25] [26] [27] . One such variant that is overexpressed in adult myotonic dystrophy type 1 was recently implicated to be of pathophysiological signi cance 28 , although the physiological roles of RyR1 variants largely remain unknown.
Further studies into the roles of RyR1 splice variants should provide important insight into not only universal intracellular Ca 2 signaling but also the tissue-speci c regulation of Ca 2 signaling in speci c tissues including brain and muscle 29 .
